報價延遲最少15分鐘:2025/06/28 20:29 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
30.22 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.94/2.57
|
|
企業價值
16.48B
|
| 資產負債 |
|
每股賬面淨值
12.03
|
| 現金流量 |
|
現金流量率
0.07
|
| 損益表 |
|
收益
5.81B
|
|
每股收益
12.23
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/28 20:29 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder. |